Uses
Beauvericin is a cyclic depsipeptide isolated from several fungal genera, notably Beauveria and Fusarium, first reported in 1969. Beauvericin exhibits broad antifungal, antibacterial, antiprotozoan and insecticidal activities. At the molecular level, beauvericin exhibits ionophoric properties, and inhibits acyl-CoA:cholesterol acyltransferase activity. Beauvericin induces apoptosis by elevating intracellular calcium levels.
References
[1] CHIEN-LIN LU. Beauvericin-induced cell apoptosis through the mitogen-activated protein kinase pathway in human nonsmall cell lung cancer A549 cells.[J]. Journal of Toxicological Sciences, 2016, 41 3: 429-437. DOI:
10.2131/jts.41.429[2] ANTON A. TONSHIN . The Fusarium mycotoxins enniatins and beauvericin cause mitochondrial dysfunction by affecting the mitochondrial volume regulation, oxidative phosphorylation and ion homeostasis[J]. Toxicology, 2010, 276 1: Pages 49-57. DOI:
10.1016/j.tox.2010.07.001[3] TANVI SHEKHAR-GUTURJA. Dual action antifungal small molecule modulates multidrug efflux and TOR signaling[J]. Nature chemical biology, 2016, 12 10: 867-875. DOI:
10.1038/nchembio.2165[4] LIEN TAEVERNIER . Blood-brain barrier transport kinetics of the cyclic depsipeptide mycotoxins beauvericin and enniatins[J]. Toxicology letters, 2016, 258: Pages 175-184. DOI:
10.1016/j.toxlet.2016.06.1741[5] CHA-GYUN SHIN. Beauvericin and enniatins H, I and MK1688 are new potent inhibitors of human immunodeficiency virus type-1 integrase[J]. Journal of Antibiotics, 2009, 62 12: 687-690. DOI:
10.1038/ja.2009.102
